Literature DB >> 10915833

Mibefradil, an I(Ca,T) blocker, effectively blocks I(Ca,L) in rabbit sinus node cells.

L Protas1, R B Robinson.   

Abstract

To test the hypothesis that the Ca(2+) channel blocker mibefradil slows heart rate due to inhibition of T-type Ca(2+) current in pacemaker cells, we studied effects of mibefradil on action potentials and ionic currents of isolated rabbit sinus node cells using the patch clamp technique. Mibefradil (100 nM and 1 microM) reduced spontaneous rate, decreased action potential amplitude and finally stopped impulse initiation. This action was not due to the drug effect on hyperpolarization-activated pacemaker current, but can be explained by attenuation of both T- and L-type Ca(2+) currents, which were inhibited by mibefradil almost equally (55% and 64% inhibition with 1 microM for T- and L-types, respectively).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10915833     DOI: 10.1016/s0014-2999(00)00364-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

Review 1.  T-type channels in the sino-atrial and atrioventricular pacemaker mechanism.

Authors:  Pietro Mesirca; Angelo G Torrente; Matteo E Mangoni
Journal:  Pflugers Arch       Date:  2014-02-27       Impact factor: 3.657

2.  Computational modeling of inhibition of voltage-gated Ca channels: identification of different effects on uterine and cardiac action potentials.

Authors:  Wing-Chiu Tong; Iffath Ghouri; Michael J Taggart
Journal:  Front Physiol       Date:  2014-10-16       Impact factor: 4.566

Review 3.  HCN Channels Modulators: The Need for Selectivity.

Authors:  Maria Novella Romanelli; Laura Sartiani; Alessio Masi; Guido Mannaioni; Dina Manetti; Alessandro Mugelli; Elisabetta Cerbai
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

Review 4.  Functional Microdomains in Heart's Pacemaker: A Step Beyond Classical Electrophysiology and Remodeling.

Authors:  Di Lang; Alexey V Glukhov
Journal:  Front Physiol       Date:  2018-11-27       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.